VEGF suppresses T‐lymphocyte infiltration in the tumor microenvironment through inhibition of NF‐κB‐induced endothelial activation-Reference-Cited by-同舟云学术

VEGF suppresses T‐lymphocyte infiltration in the tumor microenvironment through inhibition of NF‐κB‐induced endothelial activation

Published:2014-10-31 Issue:1 Volume:29 Page:227-238
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Huang Hua¹,Langenkamp Elise¹,Georganaki Maria¹,Loskog Angelica¹,Fuchs Peder Fredlund²,Dieterich Lothar C.¹,Kreuger Johan²,Dimberg Anna¹

Affiliation:

1. Department of Immunology, Genetics and PathologyThe Rudbeck LaboratoryBiomedical CenterScience for Life LaboratoryUppsala UniversityUppsalaSweden

2. Department of Medical Biochemistry and MicrobiologyBiomedical CenterScience for Life LaboratoryUppsala UniversityUppsalaSweden

Funder

Cancerfonden

Vetenskapsrådet

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.14-250985

Reference48 articles.

1. Hallmarks of Cancer: The Next Generation

2. Getting to the site of inflammation: the leukocyte adhesion cascade updated

3. Evolving functions of endothelial cells in inflammation

4. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor‐associated endothelium;Griffioen A. W.;Blood,1996

5. Endothelial intercellular adhesion molecule‐1 expression is suppressed in human malignancies: the role of angiogenic factors;Griffioen A. W.;Cancer Res.,1996

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Targeting Endothelial Rap1B to Overcome Vascular Immunosuppression in Cancer;International Journal of Molecular Sciences;2024-09-12

2. Effectiveness and safety of anlotinib plus anti-programmed cell death 1/ligand 1 (anti-PD-1/PD-L1) antibodies as maintenance therapy after first-line chemotherapy combined with anti-PD-1/PD-L1 antibodies in extensive-stage small cell lung cancer: a real-world study;Journal of Thoracic Disease;2024-07

3. Enhancing antitumor efficacy of oncolytic virus M1 via albendazole-sustained CD8+ T cell activation;Molecular Therapy: Oncology;2024-06

4. Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors;Frontiers in Cell and Developmental Biology;2024-04-25

5. Endothelial cells in tumor microenvironment: insights and perspectives;Frontiers in Immunology;2024-02-15